↓ Skip to main content

Emerging technologies in autoantibody testing for rheumatic diseases

Overview of attention for article published in Arthritis Research & Therapy, July 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
72 Mendeley
Title
Emerging technologies in autoantibody testing for rheumatic diseases
Published in
Arthritis Research & Therapy, July 2017
DOI 10.1186/s13075-017-1380-3
Pubmed ID
Authors

Nancy J. Olsen, May Y. Choi, Marvin J. Fritzler

Abstract

Testing for the presence of antinuclear antibodies (ANAs) is a key step in the diagnosis of systemic lupus erythematosus (SLE) and other systemic autoimmune rheumatic diseases (SARD). The standard slide-based indirect immunofluorescence (IIF) test is widely used, but is limited by a relative lack of specificity for SLE and not all SARD-ANAs are detected. Alternative immunoassays that might offer enhanced diagnostic and prognostic information have evolved, and some of these have entered clinical practice. This review summarizes the current state of ANA testing and multiplex techniques for detecting other autoantibodies, the possibility of point-of-care testing, and approaches for applications in early disease stages.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 72 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 21%
Student > Ph. D. Student 10 14%
Other 7 10%
Student > Bachelor 7 10%
Student > Master 7 10%
Other 15 21%
Unknown 11 15%
Readers by discipline Count As %
Medicine and Dentistry 23 32%
Biochemistry, Genetics and Molecular Biology 15 21%
Immunology and Microbiology 12 17%
Agricultural and Biological Sciences 4 6%
Engineering 2 3%
Other 5 7%
Unknown 11 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 July 2017.
All research outputs
#16,102,263
of 25,450,869 outputs
Outputs from Arthritis Research & Therapy
#2,338
of 3,387 outputs
Outputs of similar age
#186,368
of 326,729 outputs
Outputs of similar age from Arthritis Research & Therapy
#40
of 55 outputs
Altmetric has tracked 25,450,869 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,387 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 326,729 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.